RT Journal Article
SR Electronic
T1 Physicians’ awareness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer carcinomatosis
JF Canadian Journal of Surgery
JO CAN J SURG
FD Canadian Medical Association
SP 237
OP 242
DO 10.1503/cjs.003912
VO 56
IS 4
A1 Gillian Spiegle
A1 Selina Schmocker
A1 Harden Huang
A1 J. Charles Victor
A1 Calvin Law
A1 J. Andrea McCart
A1 Erin Diane Kennedy
YR 2013
UL http://canjsurg.ca/content/56/4/237.abstract
AB Background: Recent trials have shown that cytoreductive surgery and heated intraperitoneal chemotherapy (S+HIPEC) for colorectal cancer carcinomatosis (CRC-C) leads to 5-year, disease-free survival rates of more than 30%. Since these data represent a substantial change in the management of CRC-C, the objectives of this study were to determine physicians’ awareness of S+HIPEC for CRC-C and physician characteristics predictive of awareness of S+HIPEC for CRC-C.Methods: This study was a mailed, cross-sectional survey of general surgeons and medical oncologists in Ontario.Results: The response rate was 44.0% (214 of 487). Most respondents were men and younger than 50 years. There was an even split between those at academic and community hospitals. Overall, 46% of respondents were aware of S+HIPEC for CRC-C, and multivariate analysis showed that there were no physician characteristics predictive of awareness of S+HIPEC for CRC-C.Conclusion: Physician awareness of S+HIPEC for CRC-C is low. Therefore, strategies to improve patient and physician knowledge about S+HIPEC for CRC-C are important to ensure appropriate treatment for patients.